References
- BennettJDuboisCPercutaneous coronary intervention, a historical perspective looking to the futureJ Thorac Dis20135336737023825778
- WilliamsDOHolubkovRYehWPercutaneous coronary intervention in the current era compared with 1985-1986: the National Heart, Lung, and Blood Institute RegistriesCirculation2000102242945295111113044
- SigwartUPuelJMirkovitchVJoffreFKappenbergerLIntravascular stents to prevent occlusion and restenosis after transluminal angioplastyN Engl J Med1987316127017062950322
- SerruysPWde JaegerePKiemeneijFA comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study GroupN Engl J Med199433184894958041413
- MenownIBNoadRGarciaEJMeredithIThe platinum chromium element stent platform: from alloy, to design, to clinical practiceAdv Ther201027312914120437213
- NakamuraSHallPGaglioneAHigh pressure assisted coronary stent implantation accomplished without intravascular ultrasound guidance and subsequent anticoagulationJ Am Coll Cardiol199729121278996290
- SabouretPRushton-SmithSKKerneisMSilvainJColletJPMontalescotGDual antiplatelet therapy: optimal timing, management, and durationEur Heart J Cardiovasc Pharmacother20151319820427533996
- MosesJWLeonMBPopmaJJSirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary arteryN Engl J Med2003349141315132314523139
- FajadetJWijnsWLaarmanGJRandomized, double-blind, multicenter study of the Endeavor zotarolimus-eluting phosphorylcholine-encapsulated stent for treatment of native coronary artery lesions: clinical and angiographic results of the ENDEAVOR II trialCirculation2006114879880616908773
- GargSSerruysPWAn update on drug-eluting stentsCurr Treat Options Cardiovasc Med2013151617823192748
- SerruysPWSilberSGargSComparison of zotarolimus-eluting and everolimus-eluting coronary stentsN Engl J Med2010363213614620554978
- IqbalJVerheyeSAbizaidADESyne novolimus-eluting coronary stent is superior to Endeavor zotarolimus-eluting coronary stent at five-year follow-up: final results of the multicentre EXCELLA II randomised controlled trialEuroIntervention20161211e1336e134226465374
- CutlipDEWindeckerSMehranRClinical end points in coronary stent trials: a case for standardized definitionsCirculation2007115172344235117470709
- ThygesenKAlpertJSJaffeASThird universal definition of myocardial infarctionEur Heart J201233202551256722922414
- de La Torre HernándezJMAlfonsoFGimenoFThrombosis of second-generation drug-eluting stents in real practice results from the multicenter Spanish registry ESTROFA-2 (Estudio Español Sobre Trombosis de Stents Farmacoactivos de Segunda Generacion-2JACC Cardiovasc Interv20103991191920850089
- AlhaddadIATabbalatRKhaderYOutcomes of middle eastern patients undergoing percutaneous coronary intervention: the primary analysis of the first Jordanian PCI registryHeart Views20171813728584584
- HammoudehAJAlhaddadIAKhaderYCardiovascular risk factors in middle eastern patients undergoing percutaneous coronary intervention: results from the first Jordanian percutaneous coronary intervention studyJ Saudi Heart Assoc201729319520228652673
- TamburinoCCapodannoDErglisAOne-year outcomes in unselected patients treated with a thin-strut, platinum-chromium, paclitaxel-eluting stent: primary endpoint results from the TAXUS Element European post-approval surveillance study (TE-PROVEEuroIntervention201510111261126625572023